StockNYSEMDT

Medtronic

88,51 $

-0.09 (-0.10%)heute

Valuation & earnings

P/E ratio: 21.8
Forward P/E: 13.82
EPS (ttm): $4.06
Forward EPS: $6.41
Price/book: 2.26
PEG ratio: 1.6
Dividend yield: 3.25%
Payout ratio: 70.2%

Financials (ttm)

Revenue (ttm): 37.5B
Revenue growth: 13.7%
Profit margin: 13.93%
Return on equity: 10.65%
Total cash: 8.8B
Total debt: 28.2B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Oct 31, 2025	1.31	1.36	+3.49%
Jan 31, 2026	1.34	1.36	+1.86%
Apr 30, 2026	1.54	1.55	+0.56%
Jul 31, 2026	1.39	1.45	+4.51%

Next earnings date: Nov 17, 2026

Analyst view

Consensus ratingBuy28 analysts

Strong buy 3Buy 16Hold 9

12-month price targetsImplied upside: +18.44%

104.83

121

LowCurrent priceHigh

Dividends

Dividend yield: 3.25%
Dividend (annual): $2.88
Ex-dividend date: Sep 25, 2026

Recent payments

Jun 26, 2026 · $0.72Mar 27, 2026 · $0.71Dec 26, 2025 · $0.71Sep 26, 2025 · $0.71Jun 27, 2025 · $0.71

Key stats

Previous close: $88.60
Day range: 88.46 – 90.28
52-week range: 73.31 – 106.33
Volume: 11M
Avg. volume: 8.1M
Market cap: 113.2B
Beta: 0.57
52-week change: -6.06%
Currency: USD

Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It a(English)

Sector: Healthcare
Industry: Medical Devices
Employees: 95,000
Headquarters: Galway, Ireland

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.